Total Payments
$85,147
2024 Payments
$1,693
Companies
38
Transactions
261
Medicare Patients
442
Medicare Billing
$97,491
Payment Breakdown by Category
Other$54,057 (63.5%)
Research$15,300 (18.0%)
Travel$7,924 (9.3%)
Food & Beverage$6,458 (7.6%)
Consulting$1,400 (1.6%)
Education$7.90 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $54,057 | 33 | 63.5% |
| Unspecified | $15,300 | 3 | 18.0% |
| Travel and Lodging | $7,924 | 28 | 9.3% |
| Food and Beverage | $6,458 | 194 | 7.6% |
| Consulting Fee | $1,400 | 2 | 1.6% |
| Education | $7.90 | 1 | 0.0% |
Payments by Type
General
$69,847
258 transactions
Research
$15,300
3 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $49,353 | 85 | $0 (2021) |
| Eli Lilly and Company | $15,300 | 3 | $0 (2021) |
| Vifor Pharma, Inc. | $14,311 | 24 | $0 (2023) |
| CSL Behring | $1,369 | 7 | $0 (2024) |
| Kowa Research Institute, Inc. | $1,252 | 9 | $0 (2017) |
| Mallinckrodt Hospital Products Inc. | $613.20 | 25 | $0 (2024) |
| Biocompatibles, Inc. | $605.00 | 1 | $0 (2018) |
| Retrophin, Inc. | $290.18 | 5 | $0 (2019) |
| PFIZER INC. | $260.34 | 20 | $0 (2024) |
| Novo Nordisk Inc | $231.98 | 7 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,693 | 20 | CSL Behring ($1,369) |
| 2023 | $1,541 | 18 | Vifor Pharma, Inc. ($1,215) |
| 2022 | $13,267 | 29 | Vifor Pharma, Inc. ($13,096) |
| 2021 | $14,490 | 16 | Eli Lilly and Company ($14,227) |
| 2020 | $3,621 | 7 | Amgen Inc. ($2,485) |
| 2019 | $12,984 | 58 | Amgen Inc. ($12,064) |
| 2018 | $27,253 | 65 | Amgen Inc. ($26,053) |
| 2017 | $10,299 | 48 | Amgen Inc. ($8,734) |
All Payment Transactions
261 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $19.00 | General |
| Category: IMMUNOLOGY | ||||||
| 11/11/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.94 | General |
| Category: IMMUNOLOGY | ||||||
| 11/07/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $17.33 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 10/17/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $443.00 | General |
| 10/17/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $151.28 | General |
| 10/17/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $35.75 | General |
| 10/17/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $28.60 | General |
| 10/16/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $508.75 | General |
| 10/16/2024 | CSL Behring | — | Travel and Lodging | In-kind items and services | $151.28 | General |
| 10/16/2024 | CSL Behring | — | Food and Beverage | In-kind items and services | $50.05 | General |
| 09/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $31.84 | General |
| Category: IMMUNOLOGY | ||||||
| 08/15/2024 | Boston Scientific Corporation | WATCHMAN FLX (Device) | Food and Beverage | In-kind items and services | $18.10 | General |
| Category: WATCHMAN FLX_IC | ||||||
| 06/28/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.32 | General |
| Category: IMMUNOLOGY | ||||||
| 05/24/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $23.28 | General |
| Category: IMMUNOLOGY | ||||||
| 04/23/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.83 | General |
| Category: IMMUNOLOGY | ||||||
| 03/18/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $27.34 | General |
| Category: VACCINES | ||||||
| 02/06/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.02 | General |
| Category: IMMUNOLOGY | ||||||
| 01/25/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $29.32 | General |
| Category: IMMUNOLOGY | ||||||
| 01/09/2024 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $27.98 | General |
| Category: IMMUNOLOGY | ||||||
| 11/16/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $30.52 | General |
| Category: IMMUNOLOGY | ||||||
| 11/09/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $24.69 | General |
| Category: IMMUNOLOGY | ||||||
| 11/06/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $20.58 | General |
| Category: IMMUNOLOGY | ||||||
| 10/02/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.92 | General |
| Category: IMMUNOLOGY | ||||||
| 09/14/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $28.06 | General |
| Category: IMMUNOLOGY | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF MONO AND COMBINATION THERAPY WITH MONOCLONAL ANTIBODIES IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS (BLAZE-4) | Eli Lilly and Company | $9,467 | 1 |
| A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS | Eli Lilly and Company | $5,833 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 42 | 98 | $14,700 | $9,201 |
| 2022 | 3 | 83 | 429 | $47,877 | $15,392 |
| 2021 | 4 | 151 | 819 | $131,976 | $42,698 |
| 2020 | 5 | 166 | 541 | $96,590 | $30,201 |
Total Patients
442
Total Services
1,887
Medicare Billing
$97,491
Procedure Codes
13
All Medicare Procedures & Services
13 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 42 | 98 | $14,700 | $9,201 | 62.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 46 | 156 | $41,667 | $13,462 | 32.3% |
| 90970 | Dialysis services, per day, less than full month service (20 years or older) | Office | 2022 | 15 | 232 | $5,800 | $1,808 | 31.2% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2022 | 22 | 41 | $410.00 | $122.37 | 29.8% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2021 | 14 | 76 | $65,512 | $22,490 | 34.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 57 | 174 | $54,810 | $16,420 | 30.0% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2021 | 21 | 426 | $10,224 | $3,359 | 32.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2021 | 59 | 143 | $1,430 | $429.00 | 30.0% |
| 90960 | Dialysis services (4 or more physician visits per month), patient 20 years of age and older | Office | 2020 | 11 | 64 | $47,872 | $15,376 | 32.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 44 | 84 | $23,856 | $7,587 | 31.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 43 | 43 | $18,662 | $5,444 | 29.2% |
| 90970 | Dialysis services, per day (less than full month service), patient 20 years of age or older | Office | 2020 | 13 | 225 | $4,950 | $1,419 | 28.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2020 | 55 | 125 | $1,250 | $374.70 | 30.0% |
About Dr. Steven Zeig, MD
Dr. Steven Zeig, MD is a Internal Medicine healthcare provider based in Hollywood, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/14/2005. The National Provider Identifier (NPI) number assigned to this provider is 1982693719.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Steven Zeig, MD has received a total of $85,147 in payments from pharmaceutical and medical device companies, with $1,693 received in 2024. These payments were reported across 261 transactions from 38 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($54,057).
As a Medicare-enrolled provider, Zeig has provided services to 442 Medicare beneficiaries, totaling 1,887 services with total Medicare billing of $97,491. Data is available for 4 years (2020–2023), covering 13 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Other Specialties Nephrology
- Location Hollywood, FL
- Active Since 10/14/2005
- Last Updated 03/02/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1982693719
Products in Payments
- Parsabiv (Biological) $44,264
- Parsabiv (Drug) $2,501
- Repatha (Biological) $1,410
- Korsuva (Drug) $1,181
- Sensipar (Drug) $800.00
- ACTHAR (Biological) $613.20
- VARITHENA (Drug) $605.00
- Nalocet (Drug) $204.27
- Veltassa (Drug) $185.91
- Kerendia (Drug) $147.96
- Prolia (Biological) $127.00
- Tresiba (Drug) $125.00
- PREVNAR - 13 (Biological) $116.32
- VIBERZI (Drug) $93.15
- XARELTO (Drug) $79.07
- Ozempic (Drug) $76.58
- FARXIGA (Drug) $69.80
- Vascepa (Drug) $67.36
- VIAGRA (Drug) $64.85
- LOKELMA (Drug) $62.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Hollywood
Jeffrey Levy, Md Phd, MD PHD
Internal Medicine — Payments: $1.5M
Internal Medicine $1.5M
Rachel Tate, Do, DO
Internal Medicine — Payments: $853,913
Internal Medicine $853,913
Dr. Juan Rondon, Md, MD
Internal Medicine — Payments: $48,378
Internal Medicine $48,378
Dr. Ari Bennett, Md, MD
Internal Medicine — Payments: $20,880
Internal Medicine $20,880
Zael Vazquez, M.d, M.D
Internal Medicine — Payments: $16,966
Internal Medicine $16,966
Dr. Moises Issa, M.d, M.D
Internal Medicine — Payments: $14,241
Internal Medicine $14,241